This inventor holds 1 USPTO granted patent. Top assignee: Uni Colloid Kabushiki Kaisha. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Sadaji Yamashita: Innovator in Sustained Release Capsule Technology
Introduction
Sadaji Yamashita is a notable inventor based in Kanagawa-ken, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained release capsules. His innovative approach has the potential to enhance the effectiveness of physiologically active substances.
Latest Patents
Yamashita holds a patent for a "Sustained release capsule and method for preparing the same." This invention involves a hard capsule primarily composed of gelatin, which contains a physiologically active substance. The outer surface of the capsule is uniformly covered with a film material made from a natural polysaccharide and polyhydric alcohol composition. This unique design allows the capsule to prevent the digestion of gelatin, ensuring that the active substance is conveyed to the small intestine without deactivation. The capsule can gradually release its contents in the intestine, making it useful for the effective utilization of the active substance.
Career Highlights
Sadaji Yamashita is associated with Uni Colloid Kabushiki Kaisha, where he has been instrumental in advancing research and development in pharmaceutical formulations. His work has garnered attention for its innovative approach to drug delivery systems.
Collaborations
Yamashita collaborates with Seiki Harada, a talented woman in the field, contributing to the advancement of their shared research interests.
Conclusion
Sadaji Yamashita's contributions to sustained release capsule technology highlight his innovative spirit and dedication to improving pharmaceutical applications. His work continues to influence the field and offers promising solutions for effective drug delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile